Thanks to Radical Larry for keeping up with the SS
Post# of 178
No changes to SS recently - good news in my opinion
1-14
1,000,000,000 Authorized Common Shares
894,659,316 Total Outstanding Common Shares
514,570,000 Total Restricted Common Shares
1-16
1,000,000,000 Authorized Common Shares
894,659,316 Total Outstanding Common Shares
514,570,000 Total Restricted Common Shares
1-18 12:41 PM
1,000,000,000 Authorized Common Shares
894,659,316 Total Outstanding Common Shares
514,570,000 Total Restricted Common Shares
Let's do the math off of the SS #'s provided by Larry:
894,659,316 - 514,570,000 =
380089316
380,089,316 - 81,000,000(*repayment to Patienttrac) = Prior float of 299M
So, as spelled out above, the only expansion in share structure was a repayment of debt, owed to Patienttrac from a prior year, which was rightfully satisfied in full. No other shares have been issued "just because". This means Rene/Toron/Pantheon have merely paid the debt originally owed to Patienttrac and are not otherwise diluting. Go with the numbers and only the numbers. This is more proof that Rene is disclosing what is actually happening. This was all out in the open in the last filing, and the SS numbers match up just as they should. The SS changed by exactly 81M, just as mentioned in the company report, and the original float of 299M coupled with the 81M delivered as promised, equals the current float of 380M. Again, everything seems to be lining up.